Pro-GeneX is the industry leader in providing ADE Risk Management Solutions to Long Term Care.
We are the only company with automated data feeds from LTC pharmacy providers that automate the process of pharmacogenetic risk evaluation as new prescriptions are written. The reports generated are digital and capable of changing over time instead of being static in nature. As clinical knowledge grows or new medications are prescribed, the reports and alerts change to adjust to new information.
Improve survey and quality measures performance
We don't believe in testing all patients. That is a revenue-driven approach. Your high-risk residents will benefit the most from our programs. Let's start there!
CMS has mandated a 30% reduction in off label use of antipsychotics/antidepressants in the post-acute care environment. The trial-and-error process of prescribing different antipsychotic medications, in search of the one that works best, often skews your QMs in the wrong direction, as each change in Rx increases the
number of occurrences.
This segment of your resident population is typically the largest user of medications.
Improvement in patient response to medications and removal of those that don't work impacts cost of care and improves resident satisfaction
Expensive medications increase your average daily expense. Targeting the more expensive drugs and the cost of an appropriate lower dose or potential alternate therapies can help your bottom line. Pharmacogenetic testing will tell you what your options are on a case by case basis.
Drugs can be broken down too quickly or improperly, requiring a higher dosage or change in medication in many cases.
Drugs are not metabolized fast enough resulting in either too little or too much of the drug in the body.
Drugs, supplements and some foods will reduce or increase the effectiveness of the medication.
(844) 794.3637 EXT 800